REDUCTION OF URATE DEPOSITION
ONGOING URATE DEPOSITION
- 0-4.0 mg/dL2,3
- 4.1-5.9 mg/dL2,4
- 6.0-6.8 mg/dL2,5,6
- >6.8 mg/dL7,8
0-4.0 mg/dL2,3
Potential to
- Resolve tophi faster
- Expedite the reduction of urate burden
- 0-4.0 mg/dL2,3
- 4.1-5.9 mg/dL2,4
- 6.0-6.8 mg/dL2,5,6
- >6.8 mg/dL7,8
4.1-5.9 mg/dL2,4
Potential to
- Slow dissolution of tophi (visible and nonvisible)2,4
- Decrease flare frequency2,4
- 0-4.0 mg/dL2,3
- 4.1-5.9 mg/dL2,4
- 6.0-6.8 mg/dL2,5,6
- >6.8 mg/dL7,8
6.0-6.8 mg/dL2,5,6
Potential to
- Slow gout progression
- Maintain urate burden, and flares can continue
- 0-4.0 mg/dL2,3
- 4.1-5.9 mg/dL2,4
- 6.0-6.8 mg/dL2,5,6
- >6.8 mg/dL7,8
>6.8 mg/dL7,8
Potential to
- Continue to deposit urate in the joints and tissues, including in the organs
- Flares can increase in frequency